Quest Diagnostics director granted 1,142 stock units
Quest Diagnostics Inc. director Wright Lassiter III received an equity grant of 1,142 shares of common stock on May 20, 2026, reported as a restricted stock unit award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quest Diagnostics Inc. director Wright Lassiter III received an equity grant of 1,142 shares of common stock on May 20, 2026, reported as a restricted stock unit award. Following this grant, he directly holds 10,317 shares, which include shares acquired through dividend reinvestment under the Deferred Compensation Plan for Directors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,142 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents an award of restricted stock units.
- F2. The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
Key Figures
Key Terms
restricted stock units financial
dividend reinvestment financial
Deferred Compensation Plan for Directors financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quest Diagnostics (DGX) report for Wright Lassiter III?
Was the Quest Diagnostics (DGX) Form 4 transaction a market buy or sell?
What does the restricted stock unit award mean for Quest Diagnostics (DGX) director compensation?
How were dividend reinvestments reported for the Quest Diagnostics (DGX) director?
AI-generated analysis. How Rhea-AI works. Not financial advice.